Article
The βLys66Tyr Variant of Human Hemoglobin as a Component of a Blood Substitute.
Advances in experimental medicine and biology - 1 Jan 2016
Silkstone R S, Silkstone G, Baath J A, Rajagopal B, Nicholls P, Reeder B J, Ronda L, Bulow L, Cooper C E
Abstract excerpt
It has been proposed that introducing tyrosine residues into human hemoglobin (e.g. βPhe41Tyr) may be able to reduce the toxicity of the ferryl heme species in extracellular hemoglobin-based oxygen carriers (HBOC) by facilitating long-range electron transfer from endogenous and exogenous antioxidants. Surface-exposed residues lying close to the solvent exposed heme edge may be good candidates for mutations. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
